C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2001
12/13/2001	CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001	CA2409877A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/12/2001	EP1162202A1 Method for obtaining polymorph a from doxazosine mesylate
12/12/2001	EP1162201A2 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
12/12/2001	EP1162196A1 Fused-ring compounds and use thereof as drugs
12/12/2001	EP1161430A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
12/12/2001	EP1161427A1 Improved process for asymmetric hydrogenation
12/12/2001	EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0861248B1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
12/12/2001	EP0785787B1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus
12/12/2001	EP0723540B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
12/12/2001	CN1326492A Crosslinking agent for carboxyl-containing polymers in heat-curable systems
12/12/2001	CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors
12/12/2001	CN1326443A Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
12/12/2001	CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III
12/12/2001	CN1326439A Phenyl-substituted cyclic enaminones
12/12/2001	CN1326347A 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
12/12/2001	CN1326114A Image element containing closed compounds for taking pictures
12/12/2001	CN1325848A Herbicidal 3-aryl-1,2,4-triazole derivative
12/12/2001	CN1076022C Cycloether compounds as sodium channel regulating agent
12/12/2001	CN1076021C L-2',3'-dideoxy nucleoside analogs as antihepatitis B (HBV) and anti-HIV agents
12/11/2001	US6329536 Reacting unsaturated nitroolefin compound with beta-dicarbonyl compound in the presence of a catalyst complex and a base, catalyst complex comprising a ligand and a metal complex
12/11/2001	US6329418 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
12/11/2001	US6329415 Aromatic heterocyclic compounds as antiinflammatory agents
12/11/2001	US6329411 Triazolyl disulphides
12/11/2001	US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001	US6329397 Hydroxy pipecolate hydroxamic acid derivatives
12/11/2001	US6329392 Substituted piperidines useful for the treatment of allergic diseases
12/11/2001	US6329389 Amine compounds, their production and use
12/11/2001	US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001	US6329370 Cardiovascular disorders and tumor necrosis factor (hereinafter tnf.sub..alpha.), a cytokine with pro-inflammatory activity
12/11/2001	US6329369 Methods of treating pain and other conditions
12/11/2001	CA1341325C Triazole antifungal agents
12/06/2001	WO2001092280A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
12/06/2001	WO2001092267A2 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001	WO2001092263A1 Novel triazolo pyrimidine compounds
12/06/2001	WO2001092236A1 4-alkyl halide triazine compounds used as herbicides
12/06/2001	WO2001092229A1 TNF-α PRODUCTION INHIBITORS
12/06/2001	WO2001092228A2 Process for the synthesis of amine ethers from secondary amino oxides
12/06/2001	WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof
12/06/2001	WO2001091754A1 Protein kinase inhibitors
12/06/2001	WO2001049673A3 Compounds and methods for modulation of estrogen receptors
12/06/2001	WO2001046178A3 Substituierte bisindolymaleimide
12/06/2001	WO2001023362A3 Rate-controlled particles
12/06/2001	WO2001019800A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/06/2001	US20010049444 Pyridine-substituted benzanilides as potassium ion channel openers
12/06/2001	US20010049385 Treating obesity; suppressing appetite; treating type 2 diabetes; treatment and/or prevention of diseases and disorders related to the histamine H3 receptor.
12/06/2001	US20010049379 Nitric oxide synthase inhibitors; treatment and prevention of central nervous system and other disorders.
12/06/2001	CA2736344A1 Tnf-.alpha. production inhibitors
12/06/2001	CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001	CA2410643A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
12/06/2001	CA2409597A1 Protein kinase inhibitors
12/05/2001	EP1160331A1 Enzymatic oxidations
12/05/2001	EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists
12/05/2001	EP1159276A2 Benzofuran-2-ones as colorants for organic materials
12/05/2001	EP1159254A1 Oxyalkylene-substituted aminophenol intermediate
12/05/2001	EP1159237A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
12/05/2001	EP1158986A1 Protease inhibitors
12/05/2001	EP1158980A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/05/2001	EP0994872B9 4-phenylpiperidine compounds
12/05/2001	EP0835244B1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors
12/05/2001	EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
12/05/2001	EP0821684B1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex
12/05/2001	EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001	EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/05/2001	EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
12/05/2001	CN1325385A Gastrin and cholecystokinin receptor ligands
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001	CN1325309A Compounds, compositions and method for treating or preventing viral infections and associated diseases
12/04/2001	US6326496 Reduction with metal hydride
12/04/2001	US6326395 Amidine or amide substituted furan derivatives
12/04/2001	US6326386 Anticoagulant
12/04/2001	US6326385 Administering poltassium channel modulator
12/04/2001	US6326380 Thrombin receptor antagonists
12/04/2001	US6326375 Containing an urea group
12/04/2001	US6326367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/04/2001	CA2237730C Method and compositions for the synthesis of dioxolane nucleosides with .beta.-configuration
11/2001
11/30/2001	CA2349057A1 Enzymatic oxidations
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090253A1 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines
11/29/2001	WO2001090121A2 Methods and compositions for treating hepatitis c virus
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001049674A3 Glycosidase inhibitors and preparation thereof
11/29/2001	WO2001046150A3 Quinolone compounds for use in treating viral infections
11/29/2001	WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/29/2001	WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001	US20010047015 1H-1,2,4-Triazole derivative containing an aryl-substituted saturated 1,3-dioxane or 1,3-dioxepane ring
11/29/2001	US20010047006 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
11/29/2001	CA2712547A1 Methods and compositions for treating hepatitis c virus

1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 694